A cooperative effect of OTX015 and ibrutinib in ALK+ ALCL provides the rationale to explore BET inhibitors in T cell lymphoma as well as in auto-immune disorders. The gene discussed is DNER; the disease is T-cell non-Hodgkin lymphoma.